Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Dexcom Invites the Diabetes Community to #seediabetes This November and Share Their Diabetes Story With Custom Continuous Glucose Monitor (CGM) Patches
Dexcom Invites the Diabetes Community to #seediabetes This November and Share Their Diabetes Story With Custom Continuous Glucose Monitor (CGM) Patches


DexCom, Inc. (NASDAQ: DXCM), a global leader in real-time continuous glucose monitoring, its global partners and Dexcom Warriors will once again help the world #SeeDiabetes and empower members of

Dexcom Invites the Diabetes Community to #seediabetes This November and Share Their Diabetes Story With Custom Continuous Glucose Monitor (CGM) Patches
Dexcom Invites the Diabetes Community to #seediabetes This November and Share Their Diabetes Story With Custom Continuous Glucose Monitor (CGM) Patches


DexCom, Inc. (NASDAQ: DXCM), a global leader in real-time continuous glucose monitoring, its global partners and Dexcom Warriors will once again help the world #SeeDiabetes and empower members of

U.S. News and World Report names Humana 2023 Best Overall Medicare Advantage Plan Company
U.S. News and World Report names Humana 2023 Best Overall Medicare Advantage Plan Company


Humana recently received recognition as U.S. News & World Report’s Best Insurance Company for Medicare Advantage in three categories for 2023.


This press release features multimedia. View the full

EQS-News: STRATEC REPORTS RESULTS FOR FIRST NINE MONTHS OF 2022
EQS-News: STRATEC REPORTS RESULTS FOR FIRST NINE MONTHS OF 2022
EQS-News: STRATEC REPORTS RESULTS FOR FIRST NINE MONTHS OF 2022
Dexcom Partners With Warriors and Nonprofits to Artfully Advocate for Access to Diabetes Care
Dexcom Partners With Warriors and Nonprofits to Artfully Advocate for Access to Diabetes Care


DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes will come together with members of the diabetes community during National Diabetes

Dexcom Partners With Warriors and Nonprofits to Artfully Advocate for Access to Diabetes Care
Dexcom Partners With Warriors and Nonprofits to Artfully Advocate for Access to Diabetes Care


DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes will come together with members of the diabetes community during National Diabetes

CORRECTING and REPLACING Acadia Healthcare Reports Third Quarter 2022 Results
CORRECTING and REPLACING Acadia Healthcare Reports Third Quarter 2022 Results


There was an inadvertent error on the supplementary table titled “Reconciliation of Net Income Attributable to Acadia Healthcare Company, Inc. to Adjusted Income Attributable to Acadia Healthcare

EQS-Adhoc: Challenging macroeconomic environment impact Fresenius Medical Care and Fresenius Group earnings in FY/22; Fresenius SE & Co. KGaA Group guidance revised
EQS-Adhoc: Challenging macroeconomic environment impact Fresenius Medical Care and Fresenius Group earnings in FY/22; Fresenius SE & Co. KGaA Group guidance revised
EQS-Adhoc: Challenging macroeconomic environment impact Fresenius Medical Care and Fresenius Group earnings in FY/22; Fresenius SE & Co. KGaA Group guidance revised
EQS-News: Fresenius Medical Care AG & Co. KGaA revises financial outlook for full year 2022
EQS-News: Fresenius Medical Care AG & Co. KGaA revises financial outlook for full year 2022
EQS-News: Fresenius Medical Care AG & Co. KGaA revises financial outlook for full year 2022
EQS-Adhoc: Fresenius Medical Care AG & Co. KGaA extends net income target range for financial year 2022
EQS-Adhoc: Fresenius Medical Care AG & Co. KGaA extends net income target range for financial year 2022
EQS-Adhoc: Fresenius Medical Care AG & Co. KGaA extends net income target range for financial year 2022
Dexcom, Adam Schefter Announce Dexcom U, the First NIL Program for College Athletes With Diabetes
Dexcom, Adam Schefter Announce Dexcom U, the First NIL Program for College Athletes With Diabetes


DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today the launch of Dexcom U, the first-ever NIL (name, image

Dexcom, Adam Schefter Announce Dexcom U, the First NIL Program for College Athletes With Diabetes
Dexcom, Adam Schefter Announce Dexcom U, the First NIL Program for College Athletes With Diabetes


DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today the launch of Dexcom U, the first-ever NIL (name, image

EQS-Adhoc: STRATEC REPORTS PRELIMINARY FIGURES FOR FIRST NINE MONTHS OF 2022 AND ADJUSTS SALES GUIDANCE
EQS-Adhoc: STRATEC REPORTS PRELIMINARY FIGURES FOR FIRST NINE MONTHS OF 2022 AND ADJUSTS SALES GUIDANCE
EQS-Adhoc: STRATEC REPORTS PRELIMINARY FIGURES FOR FIRST NINE MONTHS OF 2022 AND ADJUSTS SALES GUIDANCE
CORRECTING and REPLACING Humana Announces Major Expansion of Florida Dental Network, Benefits
CORRECTING and REPLACING Humana Announces Major Expansion of Florida Dental Network, Benefits


First bullet point under More Help for Floridians Eligible for Both Medicare and Medicaid section of release dated October 17, 2022, should read: Healthy Options Allowance provides eligible members

Waters Automates Solid Phase Extraction of Biological, Food and Environmental Samples with Andrew+ Pipetting Robot
Waters Automates Solid Phase Extraction of Biological, Food and Environmental Samples with Andrew+ Pipetting Robot


Waters Corporation (NYSE:WAT) today introduced Extraction+ Connected Device, a new software-controlled product for the Waters™ Andrew+™ Pipetting Robot that automates the preparation of biological

Humana Foundation Invests $13 Million in Health Equity Innovation and Creating Healthy Emotional Connections for Vulnerable Populations
Humana Foundation Invests $13 Million in Health Equity Innovation and Creating Healthy Emotional Connections for Vulnerable Populations


The Humana Foundation, philanthropic arm of Humana Inc. (NYSE: HUM) for the past 40 years, today announced the first grants reflecting its elevated focus on advancing health equity and improving

Waters Marks 25 Years in Ireland with €6 Million Clinical Diagnostics R&D Center Expansion in Wexford
Waters Marks 25 Years in Ireland with €6 Million Clinical Diagnostics R&D Center Expansion in Wexford


Waters Corporation (NYSE: WAT) today announced a combined investment of up to €6 million with support from IDA Ireland to expand its operations in Drinagh, Wexford to fund research and development

Markteinführung des Dexcom G7 in Großbritannien, Irland, Deutschland, Österreich und Hongkong – Start des globalen Rollouts des weltweit leistungsstärksten Systems zur kontinuierlichen Blutzuckerüberwachung
Markteinführung des Dexcom G7 in Großbritannien, Irland, Deutschland, Österreich und Hongkong – Start des globalen Rollouts des weltweit leistungsstärksten Systems zur kontinuierlichen Blutzuckerüberwachung


DexCom, Inc. (Nasdaq: DXCM), der weltweit führende Anbieter von Systemen zur kontinuierlichen Blutzuckermessung in Echtzeit für Menschen mit Diabetes, gab heute die Einführung des Dexcom G7 Systems

Markteinführung des Dexcom G7 in Großbritannien, Irland, Deutschland, Österreich und Hongkong – Start des globalen Rollouts des weltweit leistungsstärksten Systems zur kontinuierlichen Blutzuckerüberwachung
Markteinführung des Dexcom G7 in Großbritannien, Irland, Deutschland, Österreich und Hongkong – Start des globalen Rollouts des weltweit leistungsstärksten Systems zur kontinuierlichen Blutzuckerüberwachung


DexCom, Inc. (Nasdaq: DXCM), der weltweit führende Anbieter von Systemen zur kontinuierlichen Blutzuckermessung in Echtzeit für Menschen mit Diabetes, gab heute die Einführung des Dexcom G7 Systems

Dexcom G7 Launches in the United Kingdom, Ireland, Germany, Austria and Hong Kong – Initiating Global Rollout of World’s Most Powerful Continuous Glucose Monitoring System
Dexcom G7 Launches in the United Kingdom, Ireland, Germany, Austria and Hong Kong – Initiating Global Rollout of World’s Most Powerful Continuous Glucose Monitoring System


DexCom, Inc. (Nasdaq: DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today the Dexcom G7 Continuous Glucose Monitoring (CGM) System is now

Dexcom G7 Launches in the United Kingdom, Ireland, Germany, Austria and Hong Kong – Initiating Global Rollout of World’s Most Powerful Continuous Glucose Monitoring System
Dexcom G7 Launches in the United Kingdom, Ireland, Germany, Austria and Hong Kong – Initiating Global Rollout of World’s Most Powerful Continuous Glucose Monitoring System


DexCom, Inc. (Nasdaq: DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today the Dexcom G7 Continuous Glucose Monitoring (CGM) System is now

ADDING MULTIMEDIA Humana significantly expands Medicare Advantage health plan offerings in 2023 with focus on greater value for members
ADDING MULTIMEDIA Humana significantly expands Medicare Advantage health plan offerings in 2023 with focus on greater value for members


Humana Inc. (NYSE: HUM) today released details of its Medicare Advantage and Medicare Prescription Drug Plan offerings for 2023 – with a clear focus on benefits and support based on what its

Waters Extends Capabilities of Flagship TA Instruments Rheometer for Efficient and Repeatable Powder Analysis
Waters Extends Capabilities of Flagship TA Instruments Rheometer for Efficient and Repeatable Powder Analysis


Waters Corporation (NYSE:WAT) today introduced new, innovative powder rheology tooling and software for its TA Instruments™ HR Rheometers allowing scientists to make preciseii, repeatable powder

Henry Ford Health and Acadia Healthcare Break Ground on New Behavioral Health Hospital
Henry Ford Health and Acadia Healthcare Break Ground on New Behavioral Health Hospital


Henry Ford Health, one of the nation’s premier academic and integrated health systems, and Acadia Healthcare, the nation’s largest stand-alone behavioral healthcare company, broke ground today on a

Waters Announces Bay State’s First LEED-Certified Chemical Manufacturing Facility
Waters Announces Bay State’s First LEED-Certified Chemical Manufacturing Facility


Waters Corporation (NYSE:WAT), a global leader in analytical instruments and software, today announced its newly built Precision Chemical Manufacturing Facility in Taunton, Mass. has achieved LEED